Clinical trial Merck - MS200647_0017 - TRAP0017
A Phase II, Multicenter, Open Label Study of Bintrafusp alfa (M7824) Monotherapy in Participants with Advanced, Unresectable Cervical Cancer with Disease Progression During or After Platinum-Containing Chemotherapy
| Cancers | |
|---|---|
| Organ | Uterus |
| Trial status | Trial closed |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 2 |
| Academic trial | Non |
| Sponsor | Merck |
| EudraCT Identifier | 2019-003583-40 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT04246489 |
| Last update |